Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 3, 2007, Pages 395-400

  Chan, K Y ^a   Zhang, Li ^a   Zuo, Zhong ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; GREEN TEA EXTRACT; DRUG DERIVATIVE;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG TRANSPORT; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; TEA; TRANSPORT KINETICS; BIOAVAILABILITY; COMPARATIVE STUDY; KINETICS; ORAL DRUG ADMINISTRATION; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CAMELLIA SINENSIS; CATECHIN; HUMANS; KINETICS; TEA;

EID: 34247580847     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.3.0009     Document Type: Article

References (22)

1. Balentine, D. A., Wiseman, S. A., Bouwens., L. C. (1997) The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37: 693-704
2. Cai, Y., Anavy, N. D., Chow, S. (2002) Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab. Dispos. 30: 1246-1249
3. Chen, L., Lee, M. J., Li, H., Yang, C. S. (1997) Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab. Dispos. 25: 1045-1050
4. Chen, Z., Zhu, Q. Y., Tsang, D., Huang, Y. (2001) Degradation of green tea catechins in tea drinks. J. Agric. Food Chem. 49: 477-482
5. Chow, H. S., Cai, Y., Alberts, D. S., Hskim, I., Dorr, R., Shahi, F., Crowell, J. A., Yang, C. S., Hara, Y. (2001) Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenol E. Cancer Epidemiol. Biomarkers Prev. 10: 53-58
6. Geleijnse, J. M., Launer, L. J., Hofman, A., Pols, H. A., Witteman, J. C. (1999) Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch. Intern. Med. 159: 2170-2174
7. Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A., Nedeljkovic, S., Pekkarinen, M., Simic, B. S., Toshima, H., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B. (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med. 155: 381-386
8. Hong, J., Lambert, J. D., Lee, S. H., Sinko, P. J., Yang, C. S. (2003) Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 310: 222-227
9. Shargel, L., Yu, A. B. C. (1999) Applied biopharmaceutics and pharmacokinetics, 4th edn. Appleton & Lange, Norwalk, CT
10. Takehiko, Y., Mujo, K. (1997) Chemistry and applications of green tea. CRC Press, Boca Raton, pp 1-13
11. Tracy, T. S. (2003) Atypical enzyme kinetics: their effect on in vitro-in vivo pharmacokinetic predictions and drug interactions. Curr. Drug Metab. 4: 341-346
12. Vaidyanathan, J. B., Walle, T. (2001) Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18: 1420-1425
13. Vaidyanathan, J. B., Walle, T. (2003) Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 307: 745-752
14. Walgren, R. A., Karnaky, K. J., Lindenmayer, G. E., Walle, T. (2000) Efflux of dietary flavonoid quercetin 4′-β-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Ther. 294: 830-836
15. Warden, B. A., Smith, L. S., Beecher, G. R., Balentine, D. A., Clevidence, B. A. (2001) Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 131: 1731-1737
16. Yang, C. S., Wang, Z. Y. (1993) Tea and cancer. J. Natl Cancer Inst. 85: 1038-1049
17. Yang, C. S., Chen, L., Lee, M., Balentine, D., Kuo, M. C., Schantz, S. P. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7: 351-354
18. Yang, Y. C., Lu, F. H., Wu, J. S., Wu, C. H., Chang, C. J. (2004) The protective effect of habitual tea consumption on hypertension. Arch. Intern. Med. 164: 1534-1540
19. Zhang, L., Zheng, Y., Chow, M. S. S., Zuo, Z. (2004) Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287: 1-12
20. Zhang, L., Chow, M. S. S., Zuo, Z. (2006) Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea catechins in Caco-2 monolayer model. J. Pharm. Pharmacol. 58: 37-44
21. Zhu, M., Chen, Y., Li, R. C. (2000) Oral absorption and bioavailability of tea catechins. Planta Med. 66: 444-447
22. Zhu, Q. Y., Hammerstone, J. F., Lazarus, S. A., Schmitz, H. H., Keen, C. L. (2003) Stabilizing effect of ascorbic acid on flavan-3-ols and dimeric procyanidins from cocoa. J. Agric. Food Chem. 51: 828-833